FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of chemical-pharmaceutical industry and deals with method of obtaining highly-dispersive paracetamol by quick cooling of paracetamol solution in system acetone-water with water content 15-30% and paracetamol concentration 80-95% of equilibrium solubility in said mixture at specified temperature by its dispersion into reservoir with liquid nitrogen, either by cooling solution on cooled in liquid nitrogen copper plate with further removal of solvents by sublimation from obtained solid mixture by step-by-step increase of temperature from -196°C to -80°C until acetone is removed completely, then to -35°C in order to disintegrate paracetamol solvate, then to -7°C for disintegration of paracetamol trihydrate and complete removal of ice in vacuumed thermostated vessel at temperature <5·10-2 mm Hg.
EFFECT: invention provides simple and efficient method of obtaining highly-disperse paracetamol.
2 cl, 9 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREPARING FINELY DIVIDED IBUPROFEN | 2012 |
|
RU2491919C1 |
METHOD FOR PREPARING FINE PHARMACEUTICAL COMPOSITIONS OF SALBUTAMOL | 2012 |
|
RU2504370C1 |
METHOD OF PRODUCING BETA-GLYCINE | 2010 |
|
RU2425025C1 |
METHOD OF OBTAINING HIGHLY DISPERSED MELOXICAME | 2011 |
|
RU2465892C1 |
HIGHLY DISPERSED COMBINED PHARMACEUTICAL COMPOSITION OF METHAZONE AND SALBUTAMOL WITH BETA-GLYCINE AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2539374C1 |
HIGHLY DISPERSIVE PHARMACEUTICAL COMPOSITION OF BUDESONIDE WITH BETA-GLYCINE AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2539376C1 |
CRYSTALLINE MODIFICATION OF 3β-HYDROXY-5-ANDROSTEN-17-ONE FVII AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2528990C1 |
ISOLATED ORTHORHOMBIC CRYSTALLINE FORM OF 4-{6-ACETYL-3-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO)PROPOXY]-2-PROPYLPHENOXY}-BUTYRIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2004 |
|
RU2317979C2 |
WATER-SOLUBLE COMPOSITION, POSSESSING ANTI-TUMOUR ACTIVITY AND METHOD FOR OBTAINING THEREOF | 2015 |
|
RU2611362C1 |
NORADRENERGIC AND SPECIFICALLY SEROTONERGIC ANXIOLYTIC AND ANTIDEPRESSANT, ITS PRODUCTION AND APPLICATION METHOD | 2020 |
|
RU2775772C2 |
Authors
Dates
2012-05-10—Published
2010-12-20—Filed